Image guided, intensity modulated radiation therapy (IG-IMRT), featuring best-in-class clinical workflows and highly conformal treatments enabled by a unique ultra-fast multi-leaf collimator (MLC). The Radixact® System shapes radiation to the tumor while sparing normal, healthy tissue.
Patients reeling from diagnoses need precise and effective treatment to get their lives back. Radiotherapy treatment teams need next-level precision and efficiency to improve patient outcomes. Clinical practices need to deliver value-based care and treat a broad range of indications with superior outcomes. The Radixact® Treatment Delivery System enables all of this with a fully integrated platform for intelligent radiosurgery treatment planning, centralized data management and ultra-precise treatment delivery. Radixact uses refined x-ray beamline and a unique high-speed multi-leaf collimator, combined with next-generation CTrue™ IR imaging technology* to deliver treatments for patients with a wide variety of individual treatment needs — and now features Synchrony® real-time delivery adaptation for targets that move during delivery.
Continuous 360o precision
driving clinical efficiency.
Integrated clinical workflows, accelerated imaging, planning and delivery enable clinicians to achieve highly precise and fast treatments.
Confidence in planning and delivering adaptive treatments.
Integrated helical fan-beam kVCT imaging, real-time motion synchronization and automated adaptive planning and dose monitoring make highly personalized, real-time adaptive radiotherapy treatment practical for every clinic and every patient.
Precisely treating virtually any indication and complexity.
True helical delivery and integrated wide-and long-field imaging facilitate the fractionation capabilities to treat a broad range of clinical indications with continuous 360o precision.
Watch game-changing precision and versatility in action.
See the new technologies and core features that take Radixact precision to entirely new levels.
Read about the clinical outcomes when treating head and neck cancer with TomoHelical and RapidArc systems.
Numerous peer-reviewed publications and clinical studies support the TomoTherapy platform. The same results are expected with the Radixact System, the next-generation TomoTherapy platform, delivering the same highly conformal and homogeneous dose distribution faster with 18% higher dose rates and 66% faster imaging times.
Give every patient the personalized precision they deserve. Efficiently create highly conformal plans that achieve results in fewer treatments. Leverage proven Synchrony® technology to automatically synchronize treatment delivery with target and patient motion — without interrupting treatment delivery or requiring uncomfortable patient restraints. Automated PreciseART® Adaptive Radiation Therapy workflows allow clinicians to easily identify candidates for re-planning, and make the use of individualized adaptive radiotherapy practical for more patients.
Leverage a single, workhorse platform to expand your treatable population and drive efficiencies across your practice. Deliver more precise and personalized treatments to every patient in less time, driving key patient outcomes while protecting your bottom line.
*510(k) pending, not available for sale in any market. Features shown are intended innovations and subject to change before release.
Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.
Learn how Accuray radiation technologies enable clinicians to get patients back to living their lives, faster. Explore coming innovations that unlock entirely new possibilities.
The following pages explore some of the many ways clinicians around the globe use Accuray technologies to deliver unique and effective treatments for a wide range of clinical indications.
Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.